719 related articles for article (PubMed ID: 25368186)
1. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
[TBL] [Abstract][Full Text] [Related]
2. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference.
Hochstrasser ML; Taylor DW; Bhat P; Guegler CK; Sternberg SH; Nogales E; Doudna JA
Proc Natl Acad Sci U S A; 2014 May; 111(18):6618-23. PubMed ID: 24748111
[TBL] [Abstract][Full Text] [Related]
3. A Tryptophan 'Gate' in the CRISPR-Cas3 Nuclease Controls ssDNA Entry into the Nuclease Site, That When Removed Results in Nuclease Hyperactivity.
He L; Matošević ZJ; Mitić D; Markulin D; Killelea T; Matković M; Bertoša B; Ivančić-Baće I; Bolt EL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799639
[TBL] [Abstract][Full Text] [Related]
4. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation.
Huo Y; Nam KH; Ding F; Lee H; Wu L; Xiao Y; Farchione MD; Zhou S; Rajashankar K; Kurinov I; Zhang R; Ke A
Nat Struct Mol Biol; 2014 Sep; 21(9):771-7. PubMed ID: 25132177
[TBL] [Abstract][Full Text] [Related]
5. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system.
Sinkunas T; Gasiunas G; Fremaux C; Barrangou R; Horvath P; Siksnys V
EMBO J; 2011 Apr; 30(7):1335-42. PubMed ID: 21343909
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli.
Hayes RP; Xiao Y; Ding F; van Erp PB; Rajashankar K; Bailey S; Wiedenheft B; Ke A
Nature; 2016 Feb; 530(7591):499-503. PubMed ID: 26863189
[TBL] [Abstract][Full Text] [Related]
7. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
[TBL] [Abstract][Full Text] [Related]
8. Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference.
Beloglazova N; Petit P; Flick R; Brown G; Savchenko A; Yakunin AF
EMBO J; 2011 Oct; 30(22):4616-27. PubMed ID: 22009198
[TBL] [Abstract][Full Text] [Related]
9. Fitting CRISPR-associated Cas3 into the helicase family tree.
Jackson RN; Lavin M; Carter J; Wiedenheft B
Curr Opin Struct Biol; 2014 Feb; 24():106-14. PubMed ID: 24480304
[TBL] [Abstract][Full Text] [Related]
10. Structural and biochemical analysis of nuclease domain of clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 3 (Cas3).
Mulepati S; Bailey S
J Biol Chem; 2011 Sep; 286(36):31896-903. PubMed ID: 21775431
[TBL] [Abstract][Full Text] [Related]
11. Cas3-stimulated runaway replication of modified ColE1 plasmids in Escherichia coli is temperature dependent.
Radovčić M; Čulo A; Ivančić-Baće I
FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31095294
[TBL] [Abstract][Full Text] [Related]
12. Repetitive DNA Reeling by the Cascade-Cas3 Complex in Nucleotide Unwinding Steps.
Loeff L; Brouns SJJ; Joo C
Mol Cell; 2018 May; 70(3):385-394.e3. PubMed ID: 29706536
[TBL] [Abstract][Full Text] [Related]
13. Cas3/I-C mediated target DNA recognition and cleavage during CRISPR interference are independent of the composition and architecture of Cascade surveillance complex.
Nimkar S; Anand B
Nucleic Acids Res; 2020 Mar; 48(5):2486-2501. PubMed ID: 31980818
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution and biochemical characterization of ribonucleoprotein complexes in Type I-E CRISPR-Cas systems.
Xiao Y; Ke A
Methods Enzymol; 2019; 616():27-41. PubMed ID: 30691647
[TBL] [Abstract][Full Text] [Related]
15. Cas3 stimulates runaway replication of a ColE1 plasmid in Escherichia coli and antagonises RNaseHI.
Ivančić-Baće I; Radovčić M; Bočkor L; Howard JL; Bolt EL
RNA Biol; 2013 May; 10(5):770-8. PubMed ID: 23406879
[TBL] [Abstract][Full Text] [Related]
16. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
Swarts DC; van der Oost J; Jinek M
Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
[TBL] [Abstract][Full Text] [Related]
18. Anti-CRISPR AcrIE2 Binds the Type I-E CRISPR-Cas Complex But Does Not Block DNA Binding.
Mejdani M; Pawluk A; Maxwell KL; Davidson AR
J Mol Biol; 2021 Feb; 433(3):166759. PubMed ID: 33338493
[TBL] [Abstract][Full Text] [Related]
19. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein.
Pawluk A; Shah M; Mejdani M; Calmettes C; Moraes TF; Davidson AR; Maxwell KL
mBio; 2017 Dec; 8(6):. PubMed ID: 29233895
[TBL] [Abstract][Full Text] [Related]
20. CRISPR RNA and anti-CRISPR protein binding to the
Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
